Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

July 5, 2018 by Alan Khadavi

Future Food Allergy Treatment

Current and future food allergy treatment has and will consist primarily of oral immunotherapy (OIT), sublingual immunotherapy (SLIT) and epicutaneous immunotherapy (EPIT), alone or in combination with Xolair (monoclonal IgE).  However, other therapies are under current investigation.  Despite advances in the field of food allergy treatment, the current therapies remain experimental because none of these approaches have FDA or other regulatory approval for use in patients.  Here I will discuss treatments that are being studied for food allergies.

Oral Immunotherapy

OIT has been studied most extensively in the form of milk, egg and peanut.  OIT results in successful desensitization (reduced reactivity while receiving therapy) in a majority of treated subjects, but sustained unresponsiveness, which is defined as reduced clinical reactivity after a period of cessation of therapy, has been achieved in only a subset.

Peanut OIT with AR101 is currently in phase 3 clinical trials to assess this highly characterized peanut OIT product for efficacy and safety for the induction of clinical desensitization in peanut allergic children, results are anticipated in 1-2 years.

AR101 a Potential Peanut Allergy Cure

Sublingual Immunotherapy

SLIT for IgE mediated food allergy has focused predominantly on treatment for patients allergic to milk, peanuts, tree nuts and fresh fruits.  These studies have shown clinical efficacy with moderate allergen-specific desensitization and a low side effect profile limited to predominantly to oral mucosa symptoms.  As with other forms of SLIT, limited conclusions can be made because of reduced participant adherence to therapy over time.  More studies need to be done to realize the full utility in clinical care.

Epicutaneous Immunotherapy

EPIT has been investigated for the treatment of peanut and milk allergy and involves daily application of an allergen patch to the back or upper arm.  Currently trials are underway for Viaskin Peanut patch.  Results have been mixed and ongoing phase 2 and phase 3 studies are in progress for both peanut and milk allergy, results should be forthcoming in the next 1-2 years.

Food Allergy Treatment Options

New Therapies

Novel investigations are underway to target food allergy.  A recent pilot study with dietary supplementation of isoflavones showed some potential.  At Mount Sinai investigators used CpG coated polynanoparticles containing peanut extract to treat mice with peanut allergy.  Chinese herbal therapy product (B-FAHF-2) is also being studied for peanut treatment.

The food allergy field is entering an exciting new ear with potential for lasting effect on disease burden.  Current treatment strategies are not without associated risk and further investigation is needed to address existing knowledge gaps, including optimal dose, duration, maintenance regimen, long term outcomes, predictors of response, cost-effectiveness, and psychosocial effect that will maximize efficacy, minimize risk and develop individual treatment approaches.  The future food allergy treatment options will positively affect patients and families affected by food allergy.

 

Filed Under: Blog, Food allergy, Immunotherapy

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page